Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.
about
Fluconazole alters the polysaccharide capsule of Cryptococcus gattii and leads to distinct behaviors in murine CryptococcosisThe CD4+ T-lymphocyte count is an important predictor for the prognosis of cryptococcosis.Endoplasmic reticulum stress and fungal pathogenesis.Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistanceComparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.Mononuclear phagocyte-mediated antifungal immunity: the role of chemotactic receptors and ligands.Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal studySystematic functional analysis of kinases in the fungal pathogen Cryptococcus neoformans.Antifungal and antiviral products of marine organisms.A paradoxical decline: intracranial lesions in two HIV-positive patients recovering from cryptococcal meningitis.Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach.Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review.Challenges and Strategies for Proteome Analysis of the Interaction of Human Pathogenic Fungi with Host Immune Cells.Identification and functional characterization of Penicillium marneffei pleiotropic drug resistance transporters ABC1 and ABC2.Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease.Differential Antifungal Activity of Human and Cryptococcal Melanins with Structural Discrepancies.In Vitro Antifungal Susceptibility of Environmental Isolates of Cryptococcus spp. from the West Region of Cameroon.Cryptococcal meningitis presenting with headache and a pustular eruption in a heart transplant patient.Targeting the Immune System with Plant Lectins to Combat Microbial Infections.Synthesis of a New Peptide-Coumarin Conjugate: A Potential Agent against Cryptococcosis.Does a learned journal require regular re-vamping?Assessing the Chemical Composition and Antimicrobial Activity of Essential Oils from Brazilian Plants-Eremanthus erythropappus (Asteraceae), Plectrantuns barbatus, and P. amboinicus (Lamiaceae).Transcriptomic Crosstalk between Fungal Invasive Pathogens and Their Host Cells: Opportunities and Challenges for Next-Generation Sequencing Methods.Activity of 3'-hydroxychalcone against Cryptococcus gattii and toxicity, and efficacy in alternative animal models.Identification of T helper (Th)1- and Th2-associated antigens of Cryptococcus neoformans in a murine model of pulmonary infection.Resistance Mechanism in a Terbinafine-Resistant Strain of Microsporum canis.Polymorphism in Mitochondrial Group I Introns among Cryptococcus neoformans and Cryptococcus gattii Genotypes and Its Association with Drug Susceptibility.First Isolation of Azole-Resistant Cryptococcus neoformans from Feline Cryptococcosis.Decreased TLR2 signal expression in peripheral blood mononuclear cell from patients with cryptococcal meningitis.Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans st
P2860
Q28544939-D59805C6-9BCF-466C-8844-0FE89F96235BQ33575765-4DDC202A-E082-47A0-89BC-62D9BBE4AA2FQ34530163-19043D22-248E-47B1-8E13-7DCBFC278AC4Q34943653-C05BF58C-E7B6-4D6D-B720-A72CE3E38A6EQ35097032-E799823C-5A6B-4BE9-A9DE-2FB725408089Q35602489-BEBA9E87-139D-4771-9BB8-3EA22114E9C8Q35700772-4530EBB7-CAC3-4DFA-8117-D6729E91FDECQ37315258-197968B2-A593-4375-B727-971A727F025FQ37634178-F514F39A-8808-495C-B8E9-C35B7A915026Q38609663-13DB387C-E319-4A53-B683-6801574D9C08Q38871364-A2C283DD-3AC8-4A34-98F9-2050F5013CE0Q38932794-4DEEDE82-EC5E-44ED-9244-582ED707ED8AQ39156155-BE41640C-BF82-4978-A2E5-43BA1B53D05EQ39335647-C659BF51-84CD-445F-AE81-C0B1D6503D6EQ40100243-054A940C-5606-4AC3-A9AB-06A44EA203F0Q40119719-071D502E-F53F-4EE6-9913-CF066D14E939Q40224360-4C74C809-CA15-4058-A4F9-D27D86B5B155Q41099935-B1CBB186-3871-4577-9921-FA6B74BD4DDDQ42372896-72BEBAB3-8856-42F0-8380-EBACFCE6D70CQ43186572-30447B97-65AF-451D-86A1-E76CBDAF8F4AQ45828036-C18D2710-CA9C-4A5C-AB6A-A3674F4FBCF2Q46729385-57773ED5-CC87-425A-A8B9-3AA18FDB10BEQ47706882-601DC8A1-E5B8-4C01-B84A-361E4CB72A10Q47963266-B04F0055-8F7B-4091-A570-2E83A8221C73Q49537152-649008E5-F9E2-4853-883F-4E923EF3869DQ50013423-F650558E-3F98-4E49-B645-3ABE4C4BE5DFQ50322018-F5DA639F-8CB8-472B-997A-560B162E13A9Q53432189-174B114F-FB06-4BA8-824C-0D73F531B16AQ53514240-A56020EE-7612-49B8-A0A1-6572EB903236Q54221729-770665BA-AEEA-4EA1-B2DA-B55AD6A3E442
P2860
Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.
@en
type
label
Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.
@en
prefLabel
Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.
@en
P2093
P2860
P1476
Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.
@en
P2093
A M Fusco-Almeida
J de C O Sardi
V L I Teodoro
P2860
P2888
P304
P356
10.1007/S10096-013-1915-8
P577
2013-07-04T00:00:00Z
P5875
P6179
1013096966